Effect of Helicobacter pylori infection and its eradication on the expression of tight junction proteins in the gastric epithelium in relation to gastric carcinogenesis

Background Tight junction proteins (TJPs) play a role in epithelial defense mechanisms. However, the effect of Helicobacter pylori (Hp) on TJPs remains unclear. This study aimed to evaluate the expression of TJPs in relation to Hp infection and eradication in gastric carcinogenesis. Methods In total, 510 subjects (284 controls and 226 gastric cancer [GC] patients) were prospectively enrolled in the study. The expression of claudin-1 and -2 (CLDN-1, -2), occludin (OCLN), and tight junction protein 1 (TJP1) was measured based on their Hp infection status in normal corpus mucosa and evaluated following Hp eradication using quantitative real-time polymerase chain reaction (qPCR) and immunohistochemistry (IHC). Results The expression of TJP1 in Hp(+) controls was significantly lower than that in Hp(-) controls (p = 0.006), whereas it was higher in Hp(+) than in Hp(-) GC patients (p = 0.001). Moreover, the increased expression of TJP1 in Hp(+) GC patients was reduced to levels in Hp(-)within a year after Hp eradication and was maintained for more than 5 years. Furthermore, IHC results for TJP1 were similar to qPCR results. In particular, the higher IHC staining intensity of TJP1 in the cytosol of GC patients (p = 0.019) decreased after Hp eradication (p = 0.040). Conclusion Hp infection affects TJP expression. The high expression of TJP1 in Hp(+) GC patients was restored to control levels after Hp eradication, suggesting that TJP1 plays a role in gastric carcinogenesis.

Automated summary

This study evaluated the expression of tight junction proteins (TJPs), including claudin-1 and -2, occludin, and tight junction protein 1 (TJP1), in relation to Helicobacter pylori (Hp) infection and eradication in gastric carcinogenesis. The results showed that Hp infection affects TJP expression, with lower expression of TJP1 in Hp(+) controls and higher expression in Hp(+) gastric cancer (GC) patients. However, the high expression of TJP1 in Hp(+) GC patients was restored to control levels after Hp eradication.